Neoantigen Derived DCs as Cancer Treatment

Clinical trial NCT05767684 · UNKNOWN

Trial details

NCT number: NCT05767684
Sponsor: National Health Research Institutes, Taiwan
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory Tumor Solid Tumor

Start date: 2023-06-01
Primary completion: 2025-03-30
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.